JD Health International (HKG:6618) recorded a 4.6% rise in attributable profit in the first quarter to 934.4 million yuan from 893.4 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.
The firm's revenue rose 26% in the three months to 16.6 billion yuan from 13.3 billion yuan previously.